Risk Factors for Neurocognitive Functioning in Children with Autosomal Recessive Polycystic Kidney Disease

Stephen R Hooper1

  • 1Department of Allied Health Sciences, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Insights

Autosomal recessive polycystic kidney disease (ARPKD) presents significant neurological challenges and impacts neurocognitive function in children. Early identification and management are crucial for improving outcomes in this rare genetic disorder.

Area of Science:

  • Pediatric Nephrology
  • Neuroscience
  • Genetics

Background:

  • Autosomal recessive polycystic kidney disease (ARPKD) is a rare genetic disorder affecting approximately 1 in 20,000 live births.
  • Neonatal mortality is high due to respiratory failure, with survivors facing progressive kidney and liver disease, often requiring dual organ transplants.
  • Neurological and neuropsychological impairments are significant concerns due to chronic illness, hypertension, organ transplantation, and critical brain development periods.

Purpose of the Study:

  • To provide an overview of the challenges in ARPKD, focusing on neurological factors and neurocognitive functioning.
  • To identify risk factors for neurological impairment in children with ARPKD.
  • To review existing studies on neurocognitive outcomes in this population.

Main Methods:

  • Mini-review of existing literature on ARPKD.
  • Analysis of factors contributing to neurological and neuropsychological impairment.
  • Discussion of studies investigating neurocognitive functioning in ARPKD patients.

Main Results:

  • Children with ARPKD face multiple risks for neurological impairment, including chronic kidney disease, hypertension, liver disease, and transplantation.
  • These risk factors are present during critical stages of brain development.
  • Limited studies exist on the neurocognitive functioning of children with ARPKD, highlighting a gap in research.

Conclusions:

  • Significant clinical and research challenges exist in studying neurocognitive functioning in pediatric ARPKD.
  • Further research is needed to understand and address the neurocognitive impact of ARPKD.
  • Recommendations for clinical and research directions are proposed for this complex condition.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
865
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
807
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
7.7K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
60
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
533
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.2K